UMGCC Paul Calabresi Clinical Oncology Training Program

UMGCC Paul Calabresi 临床肿瘤学培训计划

基本信息

批准号：
7470184
负责人：
EDWARD A. SAUSVILLE
金额：
$ 29.5万
依托单位：
UNIVERSITY OF MARYLAND BALTIMORE
依托单位国家：
美国
项目类别：
财政年份：
2008
资助国家：
美国
起止时间：
2008-09-05 至 2013-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7470184
关键词：
Abdomen Address Advisory Committees Affect Ally American Association of Cancer Research Antineoplastic Agents Applications Grants Appointment Area Aromatase Inhibition Arts Award Baltimore Basic Science Biological Biology Biotechnology Breast Cancer Treatment Cancer Center Chronic Lymphocytic Leukemia Class Clinical Clinical Oncology Clinical Protocols Clinical Research Clinical Research Curriculum Award Clinical Trials Clinical Trials Design Combined Modality Therapy Commit Community Networks Country Dental Assistants Development Diagnostic Procedure Disease Management Doctor of Medicine Doctor of Philosophy Drug Formulations Drug resistance Education and Outreach Educational Curriculum End Point Environment Epidemiology Evaluation Faculty Fortune Funding Genitourinary Neoplasms Goals Grant Gynecologic Oncology Head Head and Neck Cancer Health Health Policy Health Services Research Hematologic Neoplasms Hematology Human Human Virology Incidence Individual Institutes Institution Interdisciplinary Study K-Series Research Career Programs Knowledge Laboratories Laws Learning Malignant Neoplasms Marrow Maryland Master of Science Medical Medical Oncologist Medical Oncology Medicare Medicine Mentors Mentorship Minority Modality Molecular Molecular Diagnostic Techniques Motor NCI Scholars Program Neoplasm Metastasis Neoplasms New Agents Numbers Oncologic Nursing Oncology Nurse Operative Surgical Procedures Outcome Study Participant Patient Education Patients Peer Review Personal Satisfaction Pharmaceutical Preparations Pharmacologic Substance Pharmacology Pharmacology and Toxicology Pharmacy Schools Pharmacy facility Phase Phase I Clinical Trials Play Population Population Sciences Postdoctoral Fellow Preparation Principal Investigator Prize Prostate Cancer Vaccine Provider Public Health Public Health Schools Qualifying Radiation Radiation Oncology Radiobiology Recording of previous events Recruitment Activity Research Research Design Research Personnel Research Project Grants Resource Sharing Resources Rural Health SECTM1 gene Schools Science Screening procedure Secure Solid Neoplasm Source Structure Surveys Survival Rate Target Populations Testing Therapeutic Therapeutic Human Experimentation Therapy Clinical Trials Time Training Training Programs Translational Research Transplantation Treatment-Related Cancer Underrepresented Minority Underserved Population United States Public Health Service Universities Vaccines Viral anticancer research base body system cancer health disparity cancer therapy career clinically relevant compliance behavior concept design drug discovery experience interest knowledge base leukemia literacy malignant breast neoplasm medical schools member mortality multidisciplinary named group novel oncology programs socioeconomics success tool treatment center tumorigenesis

项目摘要

DESCRIPTION (provided by applicant): The University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) Paul Calabresi Clinical Oncology Training Program will support career development and training of Calabresi Scholars in clinical oncology translational research. UMGCC Calabresi Scholars will have an M.D., D.O., or equivalent clinical degree, have finished clinical training, and be ready for a junior faculty appointment. In addition, Ph.D.s, Pharm.D.s, or R.N.s with a Ph.D. who have finished at least one post-doctoral experience and who are committing to a career in clinical oncology translational research are eligible. The themes to be promoted in the UMGCC Scholars Program reflect areas of UMGCC strength: multimodality treatment strategies for cancer; drug discovery and development; and clinical cancer research in underserved minority populations. The Program will provide a didactic learning experience leading to a Master of Science in Clinical Research; a clinical research experience that will focus each Scholar's development of a cancer therapy - related clinical trial to answer a hypothesis-based clinical research question with translational endpoints; and a basic/population science activity which will tie to the clinical protocol translational question. The Scholars will be assisted in these goals by each Scholar having a Mentorship Committee consisting of a Clinical Mentor, a Basic/Population Science Mentor, and a Biostatistical Mentor. In addition, an independent Grant Application Development Committee will be formed for each Scholar, unrelated to the Scholar's Mentor Committee, to promote success of the Scholar in securing independent, peer reviewed funding. The UMGCC Program is distinguished by a number of features including 1) participation and support from six professional Schools at the University of Maryland, Baltimore (UMB Schools of Medicine, Pharmacy, Nursing, Dental, Law and the newly formed UMB School of Public Health); 2) experienced, well-funded multidisciplinary mentors; 3) the strength of UMs existing K30 Clinical Research Curriculum for the Calabresi Scholars' didactic training; 4) close coordination and the sharing of resources with existing K12s, particularly the UM Multidisciplinary Clinical Research Career Development Award; 5) a clinical research base consisting of >150 open and accruing clinical trials reflecting multidisciplinary clinical expertise and Institutional commitment to support clinical research.

描述（由申请人提供）：马里兰大学 Marlene 和 Stewart Greenebaum 癌症中心 (UMGCC) Paul Calabresi 临床肿瘤学培训计划将支持 Calabresi 学者在临床肿瘤学转化研究方面的职业发展和培训。 UMGCC Calabresi 学者将拥有医学博士、医学博士或同等临床学位，已完成临床培训，并为初级教师任命做好准备。此外，博士、药学博士或拥有博士学位的注册护士。已完成至少一次博士后经历并致力于临床肿瘤学转化研究职业的人符合资格。 UMGCC 学者计划推广的主题反映了 UMGCC 的优势领域：癌症的多模式治疗策略；药物发现和开发；以及服务不足的少数群体的临床癌症研究。该计划将提供教学学习经验，最终获得临床研究理学硕士学位；临床研究经验，重点是每位学者开发癌症治疗相关的临床试验，以回答基于假设的临床研究问题和转化终点；以及与临床方案转化问题相关的基础/人口科学活动。每位学者都设有一个由临床导师、基础/人口科学导师和生物统计导师组成的导师委员会，协助学者实现这些目标。此外，将为每位学者成立一个独立的拨款申请开发委员会，与学者导师委员会无关，以促进学者成功获得独立的同行评审资金。 UMGCC 计划具有许多特点，包括 1) 来自马里兰大学巴尔的摩分校六个专业学院（UMB 医学院、药学院、护理学院、牙科学院、法学院和新成立的 UMB 公共卫生学院）的参与和支持; 2）经验丰富、资金雄厚的多学科导师； 3) UM现有的K30临床研究课程对于卡拉布雷西学者教学培训的优势； 4）与现有的K12密切协调和资源共享，特别是UM多学科临床研究职业发展奖； 5) 临床研究基地，由超过 150 个开放和累积的临床试验组成，反映多学科临床专业知识和支持临床研究的机构承诺。